| Locus | Gene | Chromosome | Protein | Mutation frequency [20] | Extrarenal features | Ref. |
| NPHP1 | NPHP1 | 2q13 | Nephrocystin-1 | 23% | SLS, JS, | [23, 24] | NPHP2 | INV | 9q31 | Inversin | 1-2% | SLS, HF VSD, situs inversus | [25] | NPHP3 | NPHP3 | 3q22.1 | Nephrocystin-3 | <1% | SLS, HF, MKS, situs inversus | [26] | NPHP4 | NPHP4 | 1p36.22 | Nephrocystin-4 or nephroretinin | 2-3% | SLS | [27, 28] | NPHP5 | IQCB1 | 3q21.1 | Nephrocystin-5 or IQ motif containing B1 | 3-4% | SLS | [29] | NPHP6 | CEP290 | 12q21.32 | Centrosomal protein 290 | 1% | LCA, SLS, JS, MKS, BBS | [30] | NPHP7 | GLIS2 | 16p13.3 | GLI similar 2 | <0.5% | | [31] | NPHP8 | RPGRIP1L | 16q12.2 | RPGRIP1-like | 0.5% | SLS, JS, MKS | [32] | NPHP9 | NEK8 | 17q11.1 | NIMA-related kinase 8 | <0.5% | SLS | [33] | NPHP10 | SDCCAG8 | 1q44 | Serologically defined colon cancer antigen 8 | <0.5% | SLS, BBS-like | [21] | NPHP11 | TMEM67 | 8q22.1 | Transmembrane protein 67 | <0.5% | JS, HF, MKS | [34] | NPHPL1 | XPNPEP3 | 22q13 | X-prolyl aminopeptidase 3 | <0.5% | cardiomyopathy, seizures | [35] | | TTC21B | 2q24.3 | Intraflagellar transport protein 139 | <1% | JS, MKS, BBS, JATD | [22] |
|
|